PSMA: From Molecular Imaging to Radioligand Therapy
PSMA: From Molecular Imaging to Radioligand Therapy
SPEAKERS: FRED SAAD, ROB HAMILTON, DAVID LAIDLEY
LEARNING OBJECTIVES:
At the conclusion of this program, participants should be able to:
- Review nuclear medicine terminology as it relates to prostate cancer and PSMA imaging and therapy
- Review how to interpret PSMA expression and how this may help in patient selection and predict response to PSMA therapy
- Review the present and future use of radioligand therapy in the management of advanced prostate cancer
ACCREDITATION
This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Urological Association. You may claim a maximum of 1 hour of credit.
This program was made possible with financial support from Advanced Accelerator Applications: A Novartis Company